Tumor microenvironment and metabolic synergy in breast cancers: Critical importance of mitochondrial fuels and function

Seminars in Oncology

Volumn 41, Issue 2, 2014, Pages 195-216

  Martinez Outschoorn, Ubaldo ^a   Sotgia, Federica ^b   Lisanti, Michael P ^b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYL COENZYME A; ANTIOXIDANT; BRCA1 PROTEIN; CAVEOLIN 1; CONNECTIVE TISSUE GROWTH FACTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; KETONE BODY; LACTIC ACID; MONOCARBOXYLATE TRANSPORTER 4; REACTIVE OXYGEN METABOLITE; STRESS ACTIVATED PROTEIN KINASE; TRANSFORMING GROWTH FACTOR BETA;

ADIPOCYTE; AMINO ACID METABOLISM; ARTICLE; AUTOPHAGY; BREAST CANCER; BREAST CARCINOMA; CACHEXIA; CANCER PROGNOSIS; CARCINOGENESIS; CARCINOMA CELL; CATABOLISM; CELL COMPARTMENTALIZATION; CITRIC ACID CYCLE; GLYCOLYSIS; HUMAN; HYPOXIA; METABOLIC SYNDROME X; METABOLIC SYNERGY; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; NONHUMAN; OBESITY; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; PHENOTYPE; POSITIVE FEEDBACK; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STROMA CELL; TUMOR GROWTH; TUMOR MICROENVIRONMENT; UPREGULATION;

ANIMALS; AUTOPHAGY; BREAST NEOPLASMS; CACHEXIA; CARCINOMA; CAVEOLIN 1; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; FIBROBLASTS; GLYCOLYSIS; HUMANS; LACTIC ACID; MITOCHONDRIA; OXIDATIVE STRESS; PHENOTYPE; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; STROMAL CELLS; TUMOR MICROENVIRONMENT;

EID: 84899713732     PISSN: 00937754     EISSN: 15328708     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2014.03.002     Document Type: Article

References (262)

1. D.C. Wallace Mitochondria and cancer Nat Rev Cancer 12 10 2012 685 698
2. M.G. Vander Heiden, J.W. Locasale, and K.D. Swanson et al. Evidence for an alternative glycolytic pathway in rapidly proliferating cells Science 329 5998 2010 1492 1499
3. J.D. Rabinowitz, and E. White Autophagy and metabolism Science 330 6009 2010 1344 1348
4. U.E. Martinez-Outschoorn, F. Sotgia, and M.P. Lisanti Power surge: supporting cells "fuel" cancer cell mitochondria Cell Metab 15 1 2012 4 5
5. U.E. Martinez-Outschoorn, Z. Lin, and C. Trimmer et al. Cancer cells metabolically "fertilize" the tumor microenvironment with hydrogen peroxide, driving the Warburg effect: implications for PET imaging of human tumors Cell Cycle 10 15 2011 2504 2520
6. O. Warburg On the origin of cancer cells Science 123 3191 1956 309 314
7. M.G. Vander Heiden, L.C. Cantley, and C.B. Thompson Understanding the Warburg effect: the metabolic requirements of cell proliferation Science 324 5930 2009 1029 1033
8. D. Whitaker-Menezes, U.E. Martinez-Outschoorn, and N. Flomenberg et al. Hyperactivation of oxidative mitochondrial metabolism in epithelial cancer cells in situ: visualizing the therapeutic effects of metformin in tumor tissue Cell Cycle 10 23 2011 4047 4064
9. P. Sonveaux, F. Vegran, and T. Schroeder et al. Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice J Clin Invest 118 12 2008 3930 3942
10. S. Pavlides, D. Whitaker-Menezes, and R. Castello-Cros et al. The reverse Warburg effect: aerobic glycolysis in cancer associated fibroblasts and the tumor stroma Cell Cycle 8 23 2009 3984 4001
11. B. Chiavarina, D. Whitaker-Menezes, and U.E. Martinez-Outschoorn et al. Pyruvate kinase expression (PKM1 and PKM2) in cancer-associated fibroblasts drives stromal nutrient production and tumor growth Cancer Biol Ther 12 12 2011 1101 1113
12. A.K. Witkiewicz, D. Whitaker-Menezes, and A. Dasgupta et al. Using the "reverse Warburg effect" to identify high-risk breast cancer patients: Stromal MCT4 predicts poor clinical outcome in triple-negative breast cancers Cell Cycle 11 6 2012 1108 1117
13. H.A. Brauer, L. Makowski, and K.A. Hoadley et al. Impact of tumor microenvironment and epithelial phenotypes on metabolism in breast cancer Clin Cancer Res 19 3 2013 571 585
14. D. Martins, F.F. Beca, B. Sousa, F. Baltazar, J. Paredes, and F. Schmitt Loss of caveolin-1 and gain of MCT4 expression in the tumor stroma: key events in the progression from an in situ to an invasive breast carcinoma Cell Cycle 12 2013 16
15. J.M. Curry, M. Tuluc, and D. Whitaker-Menezes et al. Cancer metabolism, stemness and tumor recurrence: MCT1 and MCT4 are functional biomarkers of metabolic symbiosis in head and neck cancer Cell Cycle 12 9 2013 1371 1384
16. G. Migneco, D. Whitaker-Menezes, and B. Chiavarina et al. Glycolytic cancer associated fibroblasts promote breast cancer tumor growth, without a measurable increase in angiogenesis: evidence for stromal-epithelial metabolic coupling Cell Cycle 9 12 2010 2412 2422
17. B. Chiavarina, D. Whitaker-Menezes, and G. Migneco et al. HIF1-alpha functions as a tumor promoter in cancer associated fibroblasts, and as a tumor suppressor in breast cancer cells: autophagy drives compartment-specific oncogenesis Cell Cycle 9 17 2010 3534 3551
18. R.M. Balliet, C. Capparelli, and C. Guido et al. Mitochondrial oxidative stress in cancer-associated fibroblasts drives lactate production, promoting breast cancer tumor growth: understanding the aging and cancer connection Cell Cycle 10 23 2011 4065 4073
19. B. Chiavarina, U.E. Martinez-Outschoorn, and D. Whitaker-Menezes et al. Metabolic reprogramming and two-compartment tumor metabolism: opposing role(s) of HIF1alpha and HIF2alpha in tumor-associated fibroblasts and human breast cancer cells Cell Cycle 11 17 2012 3280 3289
20. H.R. Christofk, M.G. Vander Heiden, and M.H. Harris et al. The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth Nature 452 7184 2008 230 233
21. D. Anastasiou, Y. Yu, and W.J. Israelsen et al. Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis Nat Chem Biol 8 10 2012 839 847
22. K.M. Parnell, J.M. Foulks, and R.N. Nix et al. Pharmacologic activation of PKM2 slows lung tumor xenograft growth Mol Cancer Ther 12 8 2013 1453 1460
23. D.P. Kelly, and R.C. Scarpulla Transcriptional regulatory circuits controlling mitochondrial biogenesis and function Genes Dev 18 4 2004 357 368
24. A.S. Tan, J.W. Baty, and M.V. Berridge The role of mitochondrial electron transport in tumorigenesis and metastasis Biochim Biophys Acta 2013
25. J.M. Ross Visualization of mitochondrial respiratory function using cytochrome c oxidase/succinate dehydrogenase (COX/SDH) double-labeling histochemistry J Vis Exp 57 2011 e3266
26. S. Kim, D.H. Kim, W.H. Jung, and J.S. Koo Succinate dehydrogenase expression in breast cancer Springerplus 2 1 2013 299
27. S. Pavlides, A. Tsirigos, and G. Migneco et al. The autophagic tumor stroma model of cancer: Role of oxidative stress and ketone production in fueling tumor cell metabolism Cell Cycle 9 17 2010 3485 3505
28. U.E. Martinez-Outschoorn, R.M. Balliet, and D.B. Rivadeneira et al. Oxidative stress in cancer associated fibroblasts drives tumor-stroma co-evolution: a new paradigm for understanding tumor metabolism, the field effect and genomic instability in cancer cells Cell Cycle 9 16 2010 3256 3276
29. K.M. Kennedy, P.M. Scarbrough, and A. Ribeiro et al. Catabolism of exogenous lactate reveals it as a legitimate metabolic substrate in breast cancer PLoS One 8 9 2013 e75154
30. A.R. Diers, K.A. Broniowska, C.F. Chang, and N. Hogg Pyruvate fuels mitochondrial respiration and proliferation of breast cancer cells: effect of monocarboxylate transporter inhibition Biochem J 444 3 2012 561 571
31. M. Skrtic, S. Sriskanthadevan, and B. Jhas et al. Inhibition of mitochondrial translation as a therapeutic strategy for human acute myeloid leukemia Cancer Cell 20 5 2011 674 688
32. C.H. Lee, S.B. Wu, and C.H. Hong et al. Aberrant cell proliferation by enhanced mitochondrial biogenesis via mtTFA in arsenical skin cancers Am J Pathol 178 5 2011 2066 2076
33. U.E. Martinez-Outschoorn, S. Pavlides, F. Sotgia, and M.P. Lisanti Mitochondrial biogenesis drives tumor cell proliferation Am J Pathol 178 5 2011 1949 1952
34. C. Szabo, C. Coletta, and C. Chao et al. Tumor-derived hydrogen sulfide, produced by cystathionine-beta-synthase, stimulates bioenergetics, cell proliferation, and angiogenesis in colon cancer Proc Natl Acad Sci U S A 110 30 2013 12474 12479
35. D. Whitaker-Menezes, U.E. Martinez-Outschoorn, and Z. Lin et al. Evidence for a stromal-epithelial "lactate shuttle" in human tumors: MCT4 is a marker of oxidative stress in cancer-associated fibroblasts Cell Cycle 10 11 2011 1772 1783
36. U.E. Martinez-Outschoorn, J.M. Curry, and Y.H. Ko et al. Oncogenes and inflammation rewire host energy metabolism in the tumor microenvironment: RAS and NFkB target stromal MCT4 Cell Cycle 12 16 2013 2580 2597
37. T. Fiaschi, A. Marini, and E. Giannoni et al. Reciprocal metabolic reprogramming through lactate shuttle coordinately influences tumor-stroma interplay Cancer Res 72 19 2012 5130 5140
38. A. Giatromanolaki, M.I. Koukourakis, A. Koutsopoulos, S. Mendrinos, and E. Sivridis The metabolic interactions between tumor cells and tumor-associated stroma (TAS) in prostatic cancer Cancer Biol Ther 13 13 2012 1284 1289
39. U.E. Martinez-Outschoorn, D. Whitaker-Menezes, and M. Valsecchi et al. Reverse warburg effect in a patient with aggressive B-cell lymphoma: is lactic acidosis a paraneoplastic syndrome? Semin Oncol 40 4 2013 403 418
40. A.P. Halestrap, and D. Meredith The SLC16 gene family-from monocarboxylate transporters (MCTs) to aromatic amino acid transporters and beyond Pflugers Arch 447 5 2004 619 628
41. N. Draoui, and O. Feron Lactate shuttles at a glance: from physiological paradigms to anti-cancer treatments Dis Model Mech 4 6 2011 727 732
42. J.R. Doherty, C. Yang, and K.E. Scott et al. Blocking lactate export by inhibiting the Myc target MCT1 disables glycolysis and glutathione synthesis Cancer Res 74 3 2014 908 920
43. A. Krzeslak, K. Wojcik-Krowiranda, and E. Forma et al. Expression of GLUT1 and GLUT3 glucose transporters in endometrial and breast cancers Pathol Oncol Res 18 3 2012 721 728
44. M.S. Ullah, A.J. Davies, and A.P. Halestrap The plasma membrane lactate transporter MCT4, but not MCT1, is up-regulated by hypoxia through a HIF-1alpha-dependent mechanism J Biol Chem 281 14 2006 9030 9037
45. S. Kim, W.H. Jung, and J.S. Koo The expression of Glut-1, CAIX, and MCT4 in mucinous carcinoma J Breast Cancer 16 2 2013 146 151
46. G.A. Brooks Intra- and extra-cellular lactate shuttles Med Sci Sports Exerc 32 4 2000 790 799
47. G.A. Brooks Anaerobic threshold: review of the concept and directions for future research Med Sci Sports Exerc 17 1 1985 22 34
48. G.A. Brooks Mammalian fuel utilization during sustained exercise Comp Biochem Physiol B Biochem Mol Biol 120 1 1998 89 107
49. E. White Deconvoluting the context-dependent role for autophagy in cancer Nat Rev Cancer 12 6 2012 401 410
50. S. Kim, H. Kim do, W.H. Jung, and J.S. Koo Metabolic phenotypes in triple-negative breast cancer Tumour Biol 34 3 2013 1699 1712
51. T.B. VanItallie, and T.H. Nufert Ketones: metabolism's ugly duckling Nutr Rev 61 10 2003 327 341
52. L. Laffel Ketone bodies: a review of physiology, pathophysiology and application of monitoring to diabetes Diabetes Metab Res Rev 15 6 1999 412 426
53. G.F. Cahill Jr, and R.L. Veech Ketoacids? Good medicine? Trans Am Clin Climatol Assoc 114 2003 149 161
54. R.L. Veech, B. Chance, Y. Kashiwaya, H.A. Lardy, and G.F. Cahill Jr Ketone bodies, potential therapeutic uses IUBMB Life. 51 4 2001 241 247
55. Y. Kashiwaya, M.T. King, and R.L. Veech Substrate signaling by insulin: a ketone bodies ratio mimics insulin action in heart Am J Cardiol 80 3A 1997 50A 64A
56. Y. Kashiwaya, K. Sato, and N. Tsuchiya et al. Control of glucose utilization in working perfused rat heart J Biol Chem 269 41 1994 25502 25514
57. K. Sato, Y. Kashiwaya, and C.A. Keon et al. Insulin, ketone bodies, and mitochondrial energy transduction Faseb J 9 8 1995 651 658
58. S.E. Hall, M.E. Wastney, T.M. Bolton, J.T. Braaten, and M. Berman Ketone body kinetics in humans: the effects of insulin-dependent diabetes, obesity, and starvation J Lipid Res 25 11 1984 1184 1194
59. K.C. Fearon, D.J. Glass, and D.C. Guttridge Cancer cachexia: mediators, signaling, and metabolic pathways Cell Metab 16 2 2012 153 166
60. R.J. DeBerardinis, and T. Cheng Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer Oncogene 29 3 2010 313 324
61. D.W. Foster, and J.D. McGarry The regulation of ketogenesis Ciba Found Symp 87 1982 120 131
62. U.E. Martinez-Outschoorn, M. Prisco, and A. Ertel et al. Ketones and lactate increase cancer cell "stemness," driving recurrence, metastasis, and poor clinical outcome in breast cancer: achieving personalized medicine via Metabolo-Genomics Cell Cycle 10 2011 8
63. G. Bonuccelli, A. Tsirigos, and D. Whitaker-Menezes et al. Ketones and lactate fuel tumor growth and metastasis: Evidence that epithelial cancer cells use oxidative mitochondrial metabolism Cell Cycle 9 17 2010 3506 3514
64. C. Mascaro, C. Buesa, J.A. Ortiz, D. Haro, and F.G. Hegardt Molecular cloning and tissue expression of human mitochondrial 3-hydroxy-3-methylglutaryl- CoA synthase Arch Biochem Biophys 317 2 1995 385 390
65. N. Camarero, C. Mascaro, C. Mayordomo, F. Vilardell, D. Haro, and P.F. Marrero Ketogenic HMGCS2 Is a c-Myc target gene expressed in differentiated cells of human colonic epithelium and down-regulated in colon cancer Mol Cancer Res 4 9 2006 645 653
66. F.G. Hegardt Mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase: a control enzyme in ketogenesis Biochem J 338 Pt 3 1999 569 582
67. S.J. Ralph, S. Rodriguez-Enriquez, J. Neuzil, and R. Moreno-Sanchez Bioenergetic pathways in tumor mitochondria as targets for cancer therapy and the importance of the ROS-induced apoptotic trigger Mol Aspects Med 31 1 2010 29 59
68. U.E. Martinez-Outschoorn, Z. Lin, D. Whitaker-Menezes, A. Howell, F. Sotgia, and M.P. Lisanti Ketone body utilization drives tumor growth and metastasis Cell Cycle 11 21 2012 3964 3971
69. S.G. Yeo, D.Y. Kim, and K.H. Kim et al. Hydroxymethylglutaryl-coenzyme a synthase 2 expression is associated with chemoradiotherapy responses in colorectal cancer Dis Colon Rectum 55 6 2012 686 694
70. U.E. Martinez-Outschoorn, Z. Lin, D. Whitaker-Menezes, A. Howell, M.P. Lisanti, and F. Sotgia Ketone bodies and two-compartment tumor metabolism: stromal ketone production fuels mitochondrial biogenesis in epithelial cancer cells Cell Cycle 11 21 2012 3956 3963
71. P.F. Finn, and J.F. Dice Ketone bodies stimulate chaperone-mediated autophagy J Biol Chem 280 27 2005 25864 25870
72. C. Capparelli, C. Guido, and D. Whitaker-Menezes et al. Autophagy and senescence in cancer-associated fibroblasts metabolically supports tumor growth and metastasis via glycolysis and ketone production Cell Cycle 11 12 2012 2285 2302
73. T. Shimazu, M.D. Hirschey, and L. Hua et al. SIRT3 deacetylates mitochondrial 3-hydroxy-3-methylglutaryl CoA synthase 2 and regulates ketone body production Cell Metab 12 6 2010 654 661
74. U.E. Martinez-Outschoorn, D. Whitaker-Menezes, and Z. Lin et al. Cytokine production and inflammation drive autophagy in the tumor microenvironment: role of stromal caveolin-1 as a key regulator Cell Cycle 10 11 2011 1784 1793
75. U.E. Martinez-Outschoorn, C. Trimmer, and Z. Lin et al. Autophagy in cancer associated fibroblasts promotes tumor cell survival: role of hypoxia, HIF1 induction and NFkappaB activation in the tumor stromal microenvironment Cell Cycle 9 17 2010 3515 3533
76. F. Sotgia, F. Del Galdo, and M.C. Casimiro et al. Caveolin-1-/- null mammary stromal fibroblasts share characteristics with human breast cancer-associated fibroblasts Am J Pathol 174 3 2009 746 761
77. M.A. McNally, and A.L. Hartman Ketone bodies in epilepsy J Neurochem 121 1 2012 28 35
78. G. Seidner, M.G. Alvarez, and J.I. Yeh et al. GLUT-1 deficiency syndrome caused by haploinsufficiency of the blood-brain barrier hexose carrier Nat Genet 18 2 1998 188 191
79. I.D. Wexler, S.G. Hemalatha, and J. McConnell et al. Outcome of pyruvate dehydrogenase deficiency treated with ketogenic diets. Studies in patients with identical mutations Neurology 49 6 1997 1655 1661
80. F.A. Wijburg, P.G. Barth, and L.A. Bindoff et al. Leigh syndrome associated with a deficiency of the pyruvate dehydrogenase complex: results of treatment with a ketogenic diet Neuropediatrics 23 3 1992 147 152
81. Y. Kim do, and J.M. Rho The ketogenic diet and epilepsy Curr Opin Clin Nutr Metab Care 11 2 2008 113 120
82. S.K. Das, S. Eder, and S. Schauer et al. Adipose triglyceride lipase contributes to cancer-associated cachexia Science 333 6039 2011 233 238
83. H.D. Mulligan, S.A. Beck, and M.J. Tisdale Lipid metabolism in cancer cachexia Br J Cancer 66 1 1992 57 61
84. A. Celik, Y. Kano, and S. Tsujinaka et al. Decrease in malonyl-CoA and its background metabolic alterations in murine model of cancer cachexia Oncol Rep 21 4 2009 1105 1111
85. F. Kallinowski, P. Vaupel, and S. Runkel et al. Glucose uptake, lactate release, ketone body turnover, metabolic micromilieu, and pH distributions in human breast cancer xenografts in nude rats Cancer Res 48 24 Pt 1 1988 7264 7272
86. L.A. Sauer, and R.T. Dauchy Ketone body, glucose, lactic acid, and amino acid utilization by tumors in vivo in fasted rats Cancer Res 43 8 1983 3497 3503
87. 11C-acetoacetate kinetics in rat brain during dietary treatments affecting ketosis Am J Physiol Endocrinol Metab 296 4 2009 E796 E801
88. F. Penna, D. Costamagna, and F. Pin et al. Autophagic degradation contributes to muscle wasting in cancer cachexia Am J Pathol 182 4 2013 1367 1378
89. A. Laine, P. Iyengar, and T.K. Pandita The role of inflammatory pathways in cancer associated cachexia and radiation resistance Mol Cancer Res 11 9 2013 967 972
90. L. Fialova, I. Malbohan, and M. Kalousova et al. Oxidative stress and inflammation in pregnancy Scand J Clin Lab Invest 66 2 2006 121 127
91. J. Kovsan, N. Bashan, A.S. Greenberg, and A. Rudich Potential role of autophagy in modulation of lipid metabolism Am J Physiol Endocrinol Metab 298 1 2010 E1 E7
92. C.D. Gonzalez, M.S. Lee, and P. Marchetti et al. The emerging role of autophagy in the pathophysiology of diabetes mellitus Autophagy 7 1 2011 2 11
93. F. Giacco, and M. Brownlee Oxidative stress and diabetic complications Circ Res 107 9 2010 1058 1070
94. N.A. Ford, L.M. Lashinger, E.H. Allott, and S.D. Hursting Mechanistic targets and phytochemical strategies for breaking the obesity-cancer link Front Oncol 3 2013 209
95. Q. Dai, Y.T. Gao, and X.O. Shu et al. Oxidative stress, obesity, and breast cancer risk: results from the Shanghai Women's Health Study J Clin Oncol 27 15 2009 2482 2488
96. S. Furukawa, T. Fujita, and M. Shimabukuro et al. Increased oxidative stress in obesity and its impact on metabolic syndrome J Clin Invest 114 12 2004 1752 1761
97. A.A. Spector The importance of free fatty acid in tumor nutrition Cancer Res 27 9 1967 1580 1586
98. S. Hefetz-Sela, and P.E. Scherer Adipocytes: impact on tumor growth and potential sites for therapeutic intervention Pharmacol Ther 138 2 2013 197 210
99. K.M. Nieman, H.A. Kenny, and C.V. Penicka et al. Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth Nat Med 17 11 2011 1498 1503
100. V. D'Esposito, F. Passaretti, and A. Hammarstedt et al. Adipocyte-released insulin-like growth factor-1 is regulated by glucose and fatty acids and controls breast cancer cell growth in vitro Diabetologia 55 10 2012 2811 2822
101. S. Orecchioni, G. Gregato, and I. Martin-Padura et al. Complementary populations of human adipose CD34+ progenitor cells promote growth, angiogenesis and metastasis of breast cancer Cancer Res 2013
102. R. Sanchez-Alvarez, U.E. Martinez-Outschoorn, and R. Lamb et al. Mitochondrial dysfunction in breast cancer cells prevents tumor growth: understanding chemoprevention with metformin Cell Cycle 12 1 2013 172 182
103. A. Legaspi, M. Jeevanandam, H.F. Starnes Jr., and M.F. Brennan Whole body lipid and energy metabolism in the cancer patient Metabolism 36 10 1987 958 963
104. M.C. Bibby, J.A. Double, S.A. Ali, K.C. Fearon, R.A. Brennan, and M.J. Tisdale Characterization of a transplantable adenocarcinoma of the mouse colon producing cachexia in recipient animals J Natl Cancer Inst 78 3 1987 539 546
105. C. Drott, H. Persson, and K. Lundholm Cardiovascular and metabolic response to adrenaline infusion in weight-losing patients with and without cancer Clin Physiol 9 5 1989 427 439
106. M.J. Tisdale Biology of cachexia J Natl Cancer Inst 89 23 1997 1763 1773
107. O. Quehenberger, and E.A. Dennis The human plasma lipidome N Engl J Med 365 19 2011 1812 1823
108. L. Yu, J. Aa, and J. Xu et al. Metabolomic phenotype of gastric cancer and precancerous stages based on gas chromatography time-of-flight mass spectrometry J Gastroenterol Hepatol 26 8 2011 1290 1297
109. D.W. Gould, I. Lahart, A.R. Carmichael, Y. Koutedakis, and G.S. Metsios Cancer cachexia prevention via physical exercise: molecular mechanisms J Cachexia Sarcopenia Muscle 4 2 2013 111 124
110. J. Huang, S.K. Das, and P. Jha et al. The PPARalpha agonist fenofibrate suppresses B-cell lymphoma in mice by modulating lipid metabolism Biochim Biophys Acta 1831 10 2013 1555 1565
111. C. Waterhouse, and J.H. Kemperman Carbohydrate metabolism in subjects with cancer Cancer Res 31 9 1971 1273 1278
112. P.A. McPherson, and J. McEneny The biochemistry of ketogenesis and its role in weight management, neurological disease and oxidative stress J Physiol Biochem 68 1 2012 141 151
113. R.T. Jagoe, C.P. Redfern, R.G. Roberts, G.J. Gibson, and T.H. Goodship Skeletal muscle mRNA levels for cathepsin B, but not components of the ubiquitin-proteasome pathway, are increased in patients with lung cancer referred for thoracotomy Clin Sci (Lond) 102 3 2002 353 361
114. G. Boden, and X. Chen Effects of fatty acids and ketone bodies on basal insulin secretion in type 2 diabetes Diabetes 48 3 1999 577 583
115. P. Herrero, L.R. Peterson, and J.B. McGill et al. Increased myocardial fatty acid metabolism in patients with type 1 diabetes mellitus J Am Coll Cardiol 47 3 2006 598 604
116. K. Zendehdel, O. Nyren, C.G. Ostenson, H.O. Adami, A. Ekbom, and W. Ye Cancer incidence in patients with type 1 diabetes mellitus: a population-based cohort study in Sweden J Natl Cancer Inst 95 23 2003 1797 1800
117. X. Shu, J. Ji, X. Li, J. Sundquist, K. Sundquist, and K. Hemminki Cancer risk among patients hospitalized for Type 1 diabetes mellitus: a population-based cohort study in Sweden Diabet Med 27 7 2010 791 797
118. M. Inoue, M. Iwasaki, T. Otani, S. Sasazuki, M. Noda, and S. Tsugane Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan Arch Intern Med 166 17 2006 1871 1877
119. E.E. Calle, C. Rodriguez, K. Walker-Thurmond, and M.J. Thun Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults N Engl J Med 348 17 2003 1625 1638
120. S. Braun, K. Bitton-Worms, and D. LeRoith The link between the metabolic syndrome and cancer Int J Biol Sci 7 7 2011 1003 1015
121. H. Der-Torossian, C.G. Gourin, and M.E. Couch Translational implications of novel findings in cancer cachexia: the use of metabolomics and the potential of cardiac malfunction Curr Opin Support Palliat Care 6 4 2012 446 450
122. P. Paterson, J. Sheath, P. Taft, and C. Wood Maternal and foetal ketone concentrations in plasma and urine Lancet 1 7495 1967 862 865
123. R.G. Douglas, and J.H. Shaw Metabolic effects of cancer Br J Surg 77 3 1990 246 254
124. C. Albanese, F.S. Machado, and H.B. Tanowitz Glutamine and the tumor microenvironment: understanding the mechanisms that fuel cancer progression Cancer Biol Ther 12 12 2011 1098 1100
125. Y.H. Ko, Z. Lin, and N. Flomenberg et al. Glutamine fuels a vicious cycle of autophagy in the tumor stroma and oxidative mitochondrial metabolism in epithelial cancer cells: implications for preventing chemotherapy resistance Cancer Biol Ther 12 12 2011 1085 1097
126. R. Possemato, K.M. Marks, and Y.D. Shaul et al. Functional genomics reveal that the serine synthesis pathway is essential in breast cancer Nature 476 7360 2011 346 350
127. M. Jain, R. Nilsson, and S. Sharma et al. Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferation Science 336 6084 2012 1040 1044
128. J.M. Phang, W. Liu, and O. Zabirnyk Proline metabolism and microenvironmental stress Annu Rev Nutr 30 2010 441 463
129. Noh S, Kim DH, Jung WH, Koo JS. Expression levels of serine/glycine metabolism-related proteins in triple negative breast cancer tissues. Tumour Biol. In press. 10.1007/s13277-013-1588-z
130. C.H. Eng, K. Yu, J. Lucas, E. White, and R.T. Abraham Ammonia derived from glutaminolysis is a diffusible regulator of autophagy Sci Signal 3 119 2010 ra31
131. M. Parry-Billings, B. Leighton, and G.D. Dimitriadis et al. The effect of tumour bearing on skeletal muscle glutamine metabolism Int J Biochem 23 9 1991 933 937
132. G. Lamonte, X. Tang, and J.L. Chen et al. Acidosis induces reprogramming of cellular metabolism to mitigate oxidative stress Cancer Metab 1 1 2013 23
133. M.J. Kim, D.H. Kim, W.H. Jung, and J.S. Koo Expression of metabolism-related proteins in triple-negative breast cancer Int J Clin Exp Pathol 7 1 2014 301 312
134. F. Weinberg, R. Hamanaka, and W.W. Wheaton et al. Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity Proc Natl Acad Sci U S A 107 19 2010 8788 8793
135. S. Kim, H. Kim do, W.H. Jung, and J.S. Koo Expression of glutamine metabolism-related proteins according to molecular subtype of breast cancer Endocr Relat Cancer 20 3 2013 339 348
136. B. Levine, and G. Kroemer Autophagy in the pathogenesis of disease Cell 132 1 2008 27 42
137. E. Ferraro, and F. Cecconi Autophagic and apoptotic response to stress signals in mammalian cells Arch Biochem Biophys 462 2 2007 210 219
138. X.H. Liang, S. Jackson, and M. Seaman et al. Induction of autophagy and inhibition of tumorigenesis by beclin 1 Nature 402 6762 1999 672 676
139. H. Saito, J. Inazawa, and S. Saito et al. Detailed deletion mapping of chromosome 17q in ovarian and breast cancers: 2-cM region on 17q21.3 often and commonly deleted in tumors Cancer Res 53 14 1993 3382 3385
140. P.A. Futreal, P. Soderkvist, and J.R. Marks et al. Detection of frequent allelic loss on proximal chromosome 17q in sporadic breast carcinoma using microsatellite length polymorphisms Cancer Res 52 9 1992 2624 2627
141. Z. Li, B. Chen, Y. Wu, F. Jin, Y. Xia, and X. Liu Genetic and epigenetic silencing of the beclin 1 gene in sporadic breast tumors BMC Cancer 10 2010 98
142. Q. Yao, J. Chen, and Y. Lv et al. The significance of expression of autophagy-related gene Beclin, Bcl-2, and Bax in breast cancer tissues Tumour Biol 32 6 2011 1163 1171
143. K.Y. Won, G.Y. Kim, Y.W. Kim, J.Y. Song, and S.J. Lim Clinicopathologic correlation of beclin-1 and bcl-2 expression in human breast cancer Hum Pathol 41 1 2010 107 112
144. T. Negri, E. Tarantino, and M. Orsenigo et al. Chromosome band 17q21 in breast cancer: significant association between beclin 1 loss and HER2/NEU amplification Genes Chromosomes Cancer 49 10 2010 901 909
145. A.F. Salem, D. Whitaker-Menezes, and Z. Lin et al. Two-compartment tumor metabolism: autophagy in the tumor microenvironment and oxidative mitochondrial metabolism (OXPHOS) in cancer cells Cell Cycle 11 13 2012 2545 2556
146. C. Trimmer, F. Sotgia, and D. Whitaker-Menezes et al. Caveolin-1 and mitochondrial SOD2 (MnSOD) function as tumor suppressors in the stromal microenvironment: a new genetically tractable model for human cancer associated fibroblasts Cancer Biol Ther 11 4 2011 383 394
147. T.M. Williams, M.W. Cheung, and D.S. Park et al. Loss of caveolin-1 gene expression accelerates the development of dysplastic mammary lesions in tumor-prone transgenic mice Mol Biol Cell 14 3 2003 1027 1042
148. T.M. Williams, F. Medina, and I. Badano et al. Caveolin-1 gene disruption promotes mammary tumorigenesis and dramatically enhances lung metastasis in vivo. Role of Cav-1 in cell invasiveness and matrix metalloproteinase (MMP-2/9) secretion J Biol Chem 279 49 2004 51630 51646
149. W.K. Wu, S.B. Coffelt, and C.H. Cho et al. The autophagic paradox in cancer therapy Oncogene 31 8 2012 939 953
150. R. Mathew, C.M. Karp, and B. Beaudoin et al. Autophagy suppresses tumorigenesis through elimination of p62 Cell 137 6 2009 1062 1075
151. N.F. Villeneuve, A. Lau, and D.D. Zhang Regulation of the Nrf2-Keap1 antioxidant response by the ubiquitin proteasome system: an insight into cullin-ring ubiquitin ligases Antioxid Redox Signal 13 11 2010 1699 1712
152. S. Kim, W.H. Jung, and J.S. Koo Differences in autophagy-related activity by molecular subtype in triple-negative breast cancer Tumour Biol 33 5 2012 1681 1694
153. V. Karantza-Wadsworth, S. Patel, and O. Kravchuk et al. Autophagy mitigates metabolic stress and genome damage in mammary tumorigenesis Genes Dev 21 13 2007 1621 1635
154. K. Degenhardt, R. Mathew, and B. Beaudoin et al. Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis Cancer Cell 10 1 2006 51 64
155. N. Mizushima, and M. Komatsu Autophagy: renovation of cells and tissues Cell 147 4 2011 728 741
156. R. Singh, Y. Xiang, and Y. Wang et al. Autophagy regulates adipose mass and differentiation in mice J Clin Invest 119 11 2009 3329 3339
157. R. Singh, S. Kaushik, and Y. Wang et al. Autophagy regulates lipid metabolism Nature 458 7242 2009 1131 1135
158. E. Farmaki, I. Chatzistamou, and P. Bourlis et al. Selection of p53-deficient stromal cells in the tumor microenvironment Genes Cancer 3 9-10 2012 592 598
159. T. Andre, N. Meuleman, and B. Stamatopoulos et al. Evidences of early senescence in multiple myeloma bone marrow mesenchymal stromal cells PLoS One 8 3 2013 e59756
160. A.R. Young, M. Narita, and M. Ferreira et al. Autophagy mediates the mitotic senescence transition Genes Dev 23 7 2009 798 803
161. Y. Hassona, N. Cirillo, and K.P. Lim et al. Progression of genotype-specific oral cancer leads to senescence of cancer-associated fibroblasts and is mediated by oxidative stress and TGF-beta Carcinogenesis 34 6 2013 1286 1295
162. I. Mercier, J. Camacho, and K. Titchen et al. Caveolin-1 and accelerated host aging in the breast tumor microenvironment: chemoprevention with rapamycin, an mTOR inhibitor and anti-aging drug Am J Pathol 181 1 2012 278 293
163. H.N. Xu, S. Nioka, B. Chance, and L.Z. Li 3-D high-resolution mapping of the heterogeneity in mitochondrial redox state of human breast tumor xenografts Adv Exp Med Biol 737 2012 169 174
164. H.N. Xu, J. Tchou, B. Chance, and L.Z. Li Imaging the redox states of human breast cancer core biopsies Adv Exp Med Biol 765 2013 343 349
165. S. Pavlides, I. Vera, and R. Gandara et al. Warburg meets autophagy: cancer-associated fibroblasts accelerate tumor growth and metastasis via oxidative stress, mitophagy, and aerobic glycolysis Antioxid Redox Signal 16 11 2012 1264 1284
166. D. Anastasiou, G. Poulogiannis, and J.M. Asara et al. Inhibition of pyruvate kinase M2 by reactive oxygen species contributes to cellular antioxidant responses Science 334 6060 2011 1278 1283
167. F. Vazquez, J.H. Lim, and H. Chim et al. PGC1alpha expression defines a subset of human melanoma tumors with increased mitochondrial capacity and resistance to oxidative stress Cancer Cell 23 3 2013 287 301
168. M. Pollak Targeting oxidative phosphorylation: why, when, and how Cancer Cell 23 3 2013 263 264
169. A. Toullec, D. Gerald, and G. Despouy et al. Oxidative stress promotes myofibroblast differentiation and tumour spreading EMBO Mol Med 2 6 2010 211 230
170. T. Nguyen, P. Nioi, and C.B. Pickett The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress J Biol Chem 284 20 2009 13291 13295
171. T. Shibata, T. Ohta, and K.I. Tong et al. Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy Proc Natl Acad Sci U S A 105 36 2008 13568 13573
172. I. Ganan-Gomez, Y. Wei, H. Yang, M.C. Boyano-Adanez, and G. Garcia-Manero Oncogenic functions of the transcription factor Nrf2 Free Radic Biol Med 65 2013 750 764
173. G.M. DeNicola, F.A. Karreth, and T.J. Humpton et al. Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis Nature 475 7354 2011 106 109
174. M. Komatsu, S. Waguri, and M. Koike et al. Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice Cell 131 6 2007 1149 1163
175. M. Komatsu, H. Kurokawa, and S. Waguri et al. The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1 Nat Cell Biol 12 3 2010 213 223
176. A. Lau, X.J. Wang, and F. Zhao et al. A noncanonical mechanism of Nrf2 activation by autophagy deficiency: direct interaction between Keap1 and p62 Mol Cell Biol 30 13 2010 3275 3285
177. K. Bensaad, A. Tsuruta, and M.A. Selak et al. TIGAR, a p53-inducible regulator of glycolysis and apoptosis Cell 126 1 2006 107 120
178. K. Bensaad, E.C. Cheung, and K.H. Vousden Modulation of intracellular ROS levels by TIGAR controls autophagy EMBO J 28 19 2009 3015 3026
179. F. Sotgia, U.E. Martinez-Outschoorn, A. Howell, R.G. Pestell, S. Pavlides, and M.P. Lisanti Caveolin-1 and cancer metabolism in the tumor microenvironment: markers, models, and mechanisms Annu Rev Pathol 7 2012 423 467
180. C. Guido, D. Whitaker-Menezes, and Z. Lin et al. Mitochondrial fission induces glycolytic reprogramming in cancer-associated myofibroblasts, driving stromal lactate production, and early tumor growth Oncotarget 3 8 2012 798 810
181. A. Agarwal, U. Munoz-Najar, U. Klueh, S.C. Shih, and K.P. Claffey N-acetyl-cysteine promotes angiostatin production and vascular collapse in an orthotopic model of breast cancer Am J Pathol 164 5 2004 1683 1696
182. J. Goh, L. Enns, and S. Fatemie et al. Mitochondrial targeted catalase suppresses invasive breast cancer in mice BMC Cancer 11 2011 191
183. F. Sotgia, U.E. Martinez-Outschoorn, and M.P. Lisanti Mitochondrial oxidative stress drives tumor progression and metastasis: should we use antioxidants as a key component of cancer treatment and prevention? BMC Med 9 2011 62
184. R.R. Nazarewicz, A. Dikalova, and A. Bikineyeva et al. Does scavenging of mitochondrial superoxide attenuate cancer prosurvival signaling pathways? Antioxid Redox Signal 19 4 2013 344 349
185. Paulsen G, Cumming KT, Holden G, et al. Vitamin C and E supplementation hampers cellular adaptation to endurance training in humans: a double-blind randomized controlled trial. J Physiol. Epub ahead of print, February 3, 2014, 10.1113/jphysiol.2013.267419
186. P.Y. Wang, W. Ma, and J.Y. Park et al. Increased oxidative metabolism in the Li-Fraumeni syndrome N Engl J Med 368 11 2013 1027 1032
187. N.A. Bhowmick, E.G. Neilson, and H.L. Moses Stromal fibroblasts in cancer initiation and progression Nature 432 7015 2004 332 337
188. R. Hill, Y. Song, R.D. Cardiff, and T. Van Dyke Selective evolution of stromal mesenchyme with p53 loss in response to epithelial tumorigenesis Cell 123 6 2005 1001 1011
189. A. Patocs, L. Zhang, and Y. Xu et al. Breast-cancer stromal cells with TP53 mutations and nodal metastases N Engl J Med 357 25 2007 2543 2551
190. D. Trachootham, G. Chen, and W. Zhang et al. Loss of p53 in stromal fibroblasts promotes epithelial cell invasion through redox-mediated ICAM1 signal Free Radic Biol Med 58 2013 1 13
191. A.A. Sablina, A.V. Budanov, G.V. Ilyinskaya, L.S. Agapova, J.E. Kravchenko, and P.M. Chumakov The antioxidant function of the p53 tumor suppressor Nat Med 11 12 2005 1306 1313
192. R. Mathew, and E. White Autophagy, stress, and cancer metabolism: what doesn't kill you makes you stronger Cold Spring Harb Symp Quant Biol 76 2011 389 396
193. M.P. Lisanti, P.E. Scherer, Z. Tang, and Caveolae Sargiacomo M. caveolin and caveolin-rich membrane domains: a signalling hypothesis Trends Cell Biol 4 7 1994 231 235
194. A.J. Koleske, D. Baltimore, and M.P. Lisanti Reduction of caveolin and caveolae in oncogenically transformed cells Proc Natl Acad Sci U S A 92 5 1995 1381 1385
195. F. Sotgia, U.E. Martinez-Outschoorn, S. Pavlides, A. Howell, R.G. Pestell, and M.P. Lisanti Understanding the Warburg effect and the prognostic value of stromal caveolin-1 as a marker of a lethal tumor microenvironment Breast Cancer Res 13 4 2011 213
196. A.K. Witkiewicz, A. Dasgupta, and F. Sotgia et al. An absence of stromal caveolin-1 expression predicts early tumor recurrence and poor clinical outcome in human breast cancers Am J Pathol 174 6 2009 2023 2034
197. E.K. Sloan, D.R. Ciocca, and N. Pouliot et al. Stromal cell expression of caveolin-1 predicts outcome in breast cancer Am J Pathol 174 6 2009 2035 2043
198. N. Qian, T. Ueno, and N. Kawaguchi-Sakita et al. Prognostic significance of tumor/stromal caveolin-1 expression in breast cancer patients Cancer Sci 102 8 2011 1590 1596
199. S.M. El-Gendi, M.F. Mostafa, and A.M. El-Gendi Stromal caveolin-1 expression in breast carcinoma. Correlation with early tumor recurrence and clinical outcome Pathol Oncol Res 18 2 2012 459 469
200. X. Ma, L. Liu, and W. Nie et al. Prognostic role of caveolin in breast cancer: a meta-analysis Breast 22 4 2013 462 469
201. S.A. Simpkins, A.M. Hanby, D.L. Holliday, and V. Speirs Clinical and functional significance of loss of caveolin-1 expression in breast cancer-associated fibroblasts J Pathol 227 4 2012 490 498
202. A. Orimo, P.B. Gupta, and D.C. Sgroi et al. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion Cell 121 3 2005 335 348
203. A.L. Correia, H. Mori, E.I. Chen, F.C. Schmitt, and M.J. Bissell The hemopexin domain of MMP3 is responsible for mammary epithelial invasion and morphogenesis through extracellular interaction with HSP90beta Genes Dev 27 7 2013 805 817
204. P.S. Soon, E. Kim, and C.K. Pon et al. Breast cancer-associated fibroblasts induce epithelial-to-mesenchymal transition in breast cancer cells Endocr Relat Cancer 20 1 2013 1 12
205. U.E. Martinez-Outschoorn, S. Pavlides, and D. Whitaker-Menezes et al. Tumor cells induce the cancer associated fibroblast phenotype via caveolin-1 degradation: implications for breast cancer and DCIS therapy with autophagy inhibitors Cell Cycle 9 12 2010 2423 2433
206. L.J. Hawinkels, M. Paauwe, and H.W. Verspaget et al. Interaction with colon cancer cells hyperactivates TGF-beta signaling in cancer-associated fibroblasts Oncogene 2012
207. O. Eickelberg, A. Pansky, and R. Mussmann et al. Transforming growth factor-beta1 induces interleukin-6 expression via activating protein-1 consisting of JunD homodimers in primary human lung fibroblasts J Biol Chem 274 18 1999 12933 12938
208. X.L. Zhang, N. Topley, T. Ito, and A. Phillips Interleukin-6 regulation of transforming growth factor (TGF)-beta receptor compartmentalization and turnover enhances TGF-beta1 signaling J Biol Chem 280 13 2005 12239 12245
209. P. Bhat-Nakshatri, T.R. Newton, R. Goulet Jr., and H. Nakshatri NF-kappaB activation and interleukin 6 production in fibroblasts by estrogen receptor-negative breast cancer cell-derived interleukin 1alpha Proc Natl Acad Sci U S A 95 12 1998 6971 6976
210. F. Hu, R. Mu, and J. Zhu et al. Hypoxia and hypoxia-inducible factor-1alpha provoke toll-like receptor signalling-induced inflammation in rheumatoid arthritis Ann Rheum Dis 2013
211. N. Erez, S. Glanz, Y. Raz, C. Avivi, and I. Barshack Cancer associated fibroblasts express pro-inflammatory factors in human breast and ovarian tumors Biochem Biophys Res Commun 437 3 2013 397 402
212. H. Kinoshita, Y. Hirata, and H. Nakagawa et al. Interleukin-6 mediates epithelial-stromal interactions and promotes gastric tumorigenesis PLoS One 8 4 2013 e60914
213. M. Al-Zoubi, A.F. Salem, and U.E. Martinez-Outschoorn et al. Creating a tumor-resistant microenvironment: cell-mediated delivery of TNFalpha completely prevents breast cancer tumor formation in vivo Cell Cycle 12 3 2012 480 490
214. F. Verrecchia, M. Pessah, A. Atfi, and A. Mauviel Tumor necrosis factor-alpha inhibits transforming growth factor-beta /Smad signaling in human dermal fibroblasts via AP-1 activation J Biol Chem 275 39 2000 30226 30231
215. K. Sumiyoshi, A. Nakao, Y. Setoguchi, R. Tsuboi, K. Okumura, and H. Ogawa TGF-beta/Smad signaling inhibits IFN-gamma and TNF-alpha-induced TARC (CCL17) production in HaCaT cells J Dermatol Sci 31 1 2003 53 58
216. R.A. Vaughan, R. Garcia-Smith, K.A. Trujillo, and M. Bisoffi Tumor necrosis factor alpha increases aerobic glycolysis and reduces oxidative metabolism in prostate epithelial cells Prostate 73 14 2013 1538 1546
217. B. Razani, X.L. Zhang, M. Bitzer, G. von Gersdorff, E.P. Bottinger, and M.P. Lisanti Caveolin-1 regulates transforming growth factor (TGF)-beta/SMAD signaling through an interaction with the TGF-beta type I receptor J Biol Chem 276 9 2001 6727 6738
218. F. Del Galdo, M.P. Lisanti, and Jimenez SA. Caveolin-1 transforming growth factor-beta receptor internalization, and the pathogenesis of systemic sclerosis Curr Opin Rheumatol 20 6 2008 713 719
219. C. Meyer, Y. Liu, and S. Dooley Caveolin and TGF-beta entanglements J Cell Physiol 228 11 2013 2097 2102
220. C. Guido, D. Whitaker-Menezes, and C. Capparelli et al. Metabolic reprogramming of cancer-associated fibroblasts by TGF-beta drives tumor growth: connecting TGF-beta signaling with Warburg-like cancer metabolism and L-lactate production Cell Cycle 11 16 2012 3019 3035
221. M. Jain, S. Rivera, and E.A. Monclus et al. Mitochondrial reactive oxygen species regulate transforming growth factor-beta signaling J Biol Chem 288 2 2013 770 777
222. C.S. Curran, and P.J. Keely Breast tumor and stromal cell responses to TGF-beta and hypoxia in matrix deposition Matrix Biol 32 2 2013 95 105
223. Y. Yu, C.H. Xiao, L.D. Tan, Q.S. Wang, X.Q. Li, and Y.M. Feng Cancer-associated fibroblasts induce epithelial-mesenchymal transition of breast cancer cells through paracrine TGF-beta signalling Br J Cancer 110 2013 724 732
224. R. Castello-Cros, D.R. Khan, J. Simons, M. Valianou, and E. Cukierman Staged stromal extracellular 3D matrices differentially regulate breast cancer cell responses through PI3K and beta1-integrins BMC Cancer 9 2009 94
225. V. Carito, G. Bonuccelli, and U.E. Martinez-Outschoorn et al. Metabolic remodeling of the tumor microenvironment: migration stimulating factor (MSF) reprograms myofibroblasts toward lactate production, fueling anabolic tumor growth Cell Cycle 11 18 2012 3403 3414
226. R. Castello-Cros, G. Bonuccelli, and A. Molchansky et al. Matrix remodeling stimulates stromal autophagy, "fueling" cancer cell mitochondrial metabolism and metastasis Cell Cycle 10 12 2011 2021 2034
227. P. de Winter, P. Leoni, and D. Abraham Connective tissue growth factor: structure-function relationships of a mosaic, multifunctional protein Growth Factors 26 2 2008 80 91
228. C. Capparelli, D. Whitaker-Menezes, and C. Guido et al. CTGF drives autophagy, glycolysis and senescence in cancer-associated fibroblasts via HIF1 activation, metabolically promoting tumor growth Cell Cycle 11 12 2012 2272 2284
229. E. Tourkina, M. Richard, and J. Oates et al. Caveolin-1 regulates leucocyte behaviour in fibrotic lung disease Ann Rheum Dis 69 6 2010 1220 1226
230. U.E. Martinez-Outschoorn, R. Balliet, and Z. Lin et al. BRCA1 mutations drive oxidative stress and glycolysis in the tumor microenvironment: implications for breast cancer prevention with antioxidant therapies Cell Cycle 11 23 2012 4402 4413
231. U.E. Martinez-Outschoorn, R.M. Balliet, and Z. Lin et al. Hereditary ovarian cancer and two-compartment tumor metabolism: epithelial loss of BRCA1 induces hydrogen peroxide production, driving oxidative stress and NFkappaB activation in the tumor stroma Cell Cycle 11 22 2012 4152 4166
232. Z.A. Sherif, and A.S. Sultan Divergent control of Cav-1 expression in non-cancerous Li-Fraumeni syndrome and human cancer cell lines Cancer Biol Ther 14 1 2013 29 38
233. F. Galbiati, D. Volonte, and J. Liu et al. Caveolin-1 expression negatively regulates cell cycle progression by inducing G(0)/G(1) arrest via a p53/p21(WAF1/Cip1)-dependent mechanism Mol Biol Cell 12 8 2001 2229 2244
234. E. Tasdemir, M.C. Maiuri, and L. Galluzzi et al. Regulation of autophagy by cytoplasmic p53 Nat Cell Biol 10 6 2008 676 687
235. P.A. Kruk, and V.A. Bohr Telomeric length in individuals and cell lines with altered p53 status Radiat Oncol Investig 7 1 1999 13 21
236. G.S. Macedo, L. LisboadaMotta, and J. Giacomazzi et al. Increased oxidative damage in carriers of the germline TP53 p.R337H mutation PLoS One 7 10 2012 e47010
237. R. Sanchez-Alvarez, U.E. Martinez-Outschoorn, and Z. Lin et al. Ethanol exposure induces the cancer-associated fibroblast phenotype and lethal tumor metabolism: implications for breast cancer prevention Cell Cycle 12 2 2013 289 301
238. A.C. Cichon, A. Pickard, and S.S. McDade et al. AKT in stromal fibroblasts controls invasion of epithelial cells Oncotarget 4 7 2013 1103 1116
239. A.J. Trimboli, C.Z. Cantemir-Stone, and F. Li et al. Pten in stromal fibroblasts suppresses mammary epithelial tumours Nature 461 7267 2009 1084 1091
240. A.F. Salem, M.S. Al-Zoubi, and D. Whitaker-Menezes et al. Cigarette smoke metabolically promotes cancer, via autophagy and premature aging in the host stromal microenvironment Cell Cycle 12 5 2013 818 825
241. C. Luo, Y. Li, and L. Yang et al. A cigarette component acrolein induces accelerated senescence in human diploid fibroblast IMR-90 cells Biogerontology 14 5 2013 503 511
242. G. Bonuccelli, R. Castello-Cros, and F. Capozza et al. The milk protein alpha-casein functions as a tumor suppressor via activation of STAT1 signaling, effectively preventing breast cancer tumor growth and metastasis Cell Cycle 11 21 2012 3972 3982
243. M. Castells, B. Thibault, J.P. Delord, and B. Couderc Implication of tumor microenvironment in chemoresistance: tumor-associated stromal cells protect tumor cells from cell death Int J Mol Sci 13 8 2012 9545 9571
244. A. Ostman The tumor microenvironment controls drug sensitivity Nat Med 18 9 2012 1332 1334
245. A.C. Johansson, A. Ansell, and F. Jerhammar et al. Cancer-associated fibroblasts induce matrix metalloproteinase-mediated cetuximab resistance in head and neck squamous cell carcinoma cells Mol Cancer Res 10 9 2012 1158 1168
246. Y. Sun, J. Campisi, and C. Higano et al. Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B Nat Med 18 9 2012 1359 1368
247. T.R. Wilson, J. Fridlyand, and Y. Yan et al. Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors Nature 487 7408 2012 505 509
248. R. Straussman, T. Morikawa, and K. Shee et al. Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion Nature 487 7408 2012 500 504
249. T. Ni Chonghaile, K.A. Sarosiek, and T.T. Vo et al. Pretreatment mitochondrial priming correlates with clinical response to cytotoxic chemotherapy Science 334 6059 2011 1129 1133
250. U.E. Martinez-Outschoorn, A. Goldberg, and Z. Lin et al. Anti-estrogen resistance in breast cancer is induced by the tumor microenvironment and can be overcome by inhibiting mitochondrial function in epithelial cancer cells Cancer Biol Ther 12 10 2011 924 938
251. U.E. Martinez-Outschoorn, Z. Lin, and Y.H. Ko et al. Understanding the metabolic basis of drug resistance: therapeutic induction of the Warburg effect kills cancer cells Cell Cycle 10 15 2011 2521 2528
252. S.K. Parks, J. Chiche, and J. Pouyssegur Disrupting proton dynamics and energy metabolism for cancer therapy Nat Rev Cancer 13 9 2013 611 623
253. K. Birsoy, T. Wang, and R. Possemato et al. MCT1-mediated transport of a toxic molecule is an effective strategy for targeting glycolytic tumors Nat Genet 45 1 2013 104 108
254. P. Seth, I. Krop, D. Porter, and K. Polyak Novel estrogen and tamoxifen induced genes identified by SAGE (serial analysis of gene expression) Oncogene 21 5 2002 836 843
255. Q. Zhang, J. Gu, and L. Li et al. Control of cyclin D1 and breast tumorigenesis by the EglN2 prolyl hydroxylase Cancer Cell 16 5 2009 413 424
256. R.B. Penney, and D. Roy Thioredoxin-mediated redox regulation of resistance to endocrine therapy in breast cancer Biochim Biophys Acta 1836 1 2013 60 79
257. M.P. Shekhar, S. Santner, K.A. Carolin, and L. Tait Direct involvement of breast tumor fibroblasts in the modulation of tamoxifen sensitivity Am J Pathol 170 5 2007 1546 1560
258. O. Pontiggia, R. Sampayo, and D. Raffo et al. The tumor microenvironment modulates tamoxifen resistance in breast cancer: a role for soluble stromal factors and fibronectin through beta1 integrin Breast Cancer Res Treat 133 2 2012 459 471
259. M. Jiang, O. Huang, and X. Zhang et al. Curcumin induces cell death and restores tamoxifen sensitivity in the antiestrogen-resistant breast cancer cell lines MCF-7/LCC2 and MCF-7/LCC9 Molecules 18 1 2013 701 720
260. G. Rong, H. Kang, Y. Wang, T. Hai, and H. Sun Candidate markers that associate with chemotherapy resistance in breast cancer through the study on Taxotere-induced damage to tumor microenvironment and gene expression profiling of carcinoma-associated fibroblasts (CAFs) PLoS One 8 8 2013 e70960
261. D. Tavares-Valente, F. Baltazar, R. Moreira, and O. Queiros Cancer cell bioenergetics and pH regulation influence breast cancer cell resistance to paclitaxel and doxorubicin J Bioenerg Biomembr 45 5 2013 467 475
262. J. Barar, and Y. Omidi Dysregulated pH in Tumor Microenvironment Checkmates Cancer Therapy Bioimpacts 3 4 2013 149 162